Conditions: Allergic Rhinitis Rhinoconjunctivitis
Keywords: allergic rhinitis birch pollen immunotherapy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 240
Healthy volunteers: no

Brief summary:
The main objective of the trial is to demonstrate the efficacy of a two months pre-seasonal treatment with AllerT 100 µg maintenance dose in reducing symptoms of allergic rhinoconjunctivitis during the following birch pollen season

Detailed description:

Arms:
arm 1: SC injections of placebo arm 2: SC injections of AllerT 25 or 50 micrograms arm 3: SC injections of AllerT 50-100 micrograms

Interventions: intervention 1: placebo intervention 2: AllerT low dose intervention 3: AllerT full dose
Intervention descriptions: intervention 1: SC injections of placebo on days 1, 7, 14, 28 and 56 intervention 2: SC injections of AllerT 25-50 micrograms on days 1, 7, 14, 28 and 56 intervention 3: SC injections of AllerT 50-100 micrograms on days 1, 7, 14, 28 and 56

Protocol document: